Tumor Necrosis Factor-alpha Concentrations in the Aqueous Humor of Patients with Glaucoma
Overview
Affiliations
Purpose: To investigate the concentration of tumor necrosis factor (TNF)-alpha in the aqueous humor of patients with glaucoma, including correlations with glaucoma subtypes and intraocular pressure.
Methods: The study population comprised 84 patients with open-angle glaucoma who were scheduled for filtration or cataract surgery. Glaucoma subgroups included 29 cases of primary open-angle glaucoma (POAG), 28 cases of normal-tension glaucoma (NTG), and 27 cases of exfoliation glaucoma (ExG). Seventy-nine patients with senile cataract were recruited as control subjects. The concentrations of TNF-alpha in the aqueous humor were measured with an enzyme-linked immunosorbent assay. The percentages of samples positive for TNF-alpha and the measured concentrations in the glaucoma and cataract groups were compared. In addition, the relationships with the glaucoma subtypes, intraocular pressure, and glaucoma severity were analyzed.
Results: A significantly higher percentage of subjects in the glaucoma group were positive for TNF-alpha compared with the cataract group (P = 0.011). The mean TNF-alpha concentrations among the positive cases were not different between the groups (P = 0.689). TNF-alpha-positive samples were higher in the POAG (13.7%) and NTG (10.7%) subgroups than in the cataract group without significance, but higher in ExG subgroup (29.6%) with significance (P = 0.001). Relationships between the TNF-alpha concentration and the intraocular pressure or the clinical stage of glaucoma were not observed.
Conclusions: TNF-alpha levels were significantly higher in the glaucoma group than in the cataract group, with a particularly large difference observed in those with ExG. The results suggest that TNF-alpha plays a key role in the progression of glaucoma.
RIP1 inhibition protects retinal ganglion cells in glaucoma models of ocular injury.
Kim B, Goncharov T, Archaimbault S, Roudnicky F, Webster J, Westenskow P Cell Death Differ. 2024; 32(2):353-368.
PMID: 39448868 PMC: 11802773. DOI: 10.1038/s41418-024-01390-7.
Shin D, Han J, Park C, Lee N, Jung K Cells. 2024; 13(12.
PMID: 38920659 PMC: 11202053. DOI: 10.3390/cells13121030.
In a novel autoimmune and high-pressure glaucoma model a complex immune response is induced.
Reinehr S, Wulf J, Theile J, Schulte K, Peters M, Fuchshofer R Front Immunol. 2024; 15:1296178.
PMID: 38515755 PMC: 10955086. DOI: 10.3389/fimmu.2024.1296178.
Glaucoma: from pathogenic mechanisms to retinal glial cell response to damage.
Fernandez-Albarral J, Ramirez A, de Hoz R, Matamoros J, Salobrar-Garcia E, Elvira-Hurtado L Front Cell Neurosci. 2024; 18:1354569.
PMID: 38333055 PMC: 10850296. DOI: 10.3389/fncel.2024.1354569.
Milla E, Ventura-Abreu N, Vendrell C, Muniesa M, Pazos M, Gasull X Int J Mol Sci. 2023; 24(15).
PMID: 37569323 PMC: 10418990. DOI: 10.3390/ijms241511949.